Roadmap for investigating epigenome deregulation and environmental origins of cancer.
File(s)Herceg_et_al-2017-International_Journal_of_Cancer.pdf (773.87 KB)
Published version
Author(s)
Type
Journal Article
Abstract
The interaction between the (epi)genetic makeup of an individual and his/her environmental exposure record (exposome) is accepted as a determinant factor for a significant proportion of human malignancies. Recent evidence has highlighted the key role of epigenetic mechanisms in mediating gene-environment interactions and translating exposures into tumorigenesis. There is also growing evidence that epigenetic changes may be risk factor-specific ("fingerprints") that should prove instrumental in the discovery of new biomarkers in cancer. Here, we review the state of the science of epigenetics associated with environmental stimuli and cancer risk, highlighting key developments in the field. Critical knowledge gaps and research needs are discussed and advances in epigenomics that may help in understanding the functional relevance of epigenetic alterations. Key elements required for causality inferences linking epigenetic changes to exposure and cancer are discussed and how these alterations can be incorporated in carcinogen evaluation and in understanding mechanisms underlying epigenome deregulation by the environment.
Date Issued
2017-08-24
Date Acceptance
2017-08-03
Citation
International Journal of Cancer, 2017, 142 (5), pp.874-882
ISSN
0020-7136
Publisher
Wiley
Start Page
874
End Page
882
Journal / Book Title
International Journal of Cancer
Volume
142
Issue
5
Copyright Statement
© 2017 International Agency for Research on Cancer (IARC/WHO); licensed by UICC
This is an open access article distributed under the terms of the Creative Commons Attribution IGO License IARC's preferred IGO license is the non-commercial: https://creativecommons.org/licenses/by-nc/3.0/igo/legalcode which permits non-commercial unrestricted use, distribution and reproduction in any medium, provided that the original work is properly cited. In any reproduction of this article there should not be any suggestion that IARC/WHO or the article endorse any specific organization or products. The use of the IARC/WHO logo is not permitted. This notice should be preserved along with the article's URL.
This is an open access article distributed under the terms of the Creative Commons Attribution IGO License IARC's preferred IGO license is the non-commercial: https://creativecommons.org/licenses/by-nc/3.0/igo/legalcode which permits non-commercial unrestricted use, distribution and reproduction in any medium, provided that the original work is properly cited. In any reproduction of this article there should not be any suggestion that IARC/WHO or the article endorse any specific organization or products. The use of the IARC/WHO logo is not permitted. This notice should be preserved along with the article's URL.
License URL
Subjects
biomarkers
cancer
environment
epigenetics
molecular mechanisms
perspectives
research gaps
Publication Status
Published online